Serious infection risk in children with psoriasis on systemic treatment: A propensity score-matched population-based study-Reference-Cited by-同舟云学术

Serious infection risk in children with psoriasis on systemic treatment: A propensity score-matched population-based study

Published:2020-06 Issue:6 Volume:82 Page:1337-1345
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Schneeweiss Maria C.,Huang Jennifer T.,Wyss Richard,Schneeweiss Sebastian,Merola Joseph F.

Funder

Brigham and Women's Hospital

Bayer

Vertex

Boehringer Ingelheim

Publisher

Elsevier BV

Subject

Dermatology

Reference41 articles.

1. Biologic and conventional systemic therapies show similar safety and efficacy in elderly and adult patients with moderate to severe psoriasis;Garber;J Drugs Dermatol,2015

2. Safety of systemic agents for the treatment of pediatric psoriasis;Bronckers;JAMA Dermatol,2017

3. Association of psoriasis with comorbidity development in children with psoriasis;Tollefson;JAMA Dermatol,2018

4. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study;Gelfand;Arch Dermatol,2005

5. The burden of childhood psoriasis;de Jager;Pediatr Dermatol,2011

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concepts of Designing and Implementing Pharmacoepidemiology Studies on the Safety of Systemic Treatments in Dermatology Practice;JID Innovations;2023-11

2. Psoriasis in children and adolescents;Monatsschrift Kinderheilkunde;2023-04-12

3. Psoriasis in children and adolescents;Die Dermatologie;2023-03-28

4. Risk of Infection in Children With Psoriasis Receiving Treatment With Ustekinumab, Etanercept, or Methotrexate Before and After Labeling Expansion;JAMA Dermatology;2023-03-01

5. Secukinumab for the Treatment of Psoriasis in Pediatrics: Patient Selection and Acceptability;Patient Preference and Adherence;2023-02